2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug Susceptible Tuberculosis

Dates: November 4, 2016

Training Format: 
Webinar

This is the 1st webinar in a 2-part series.  Additional information on the 2nd webinar will be available soon.

90-Minute Webinar

Originally aired November 4, 2016

This 90-minute webinar introduces the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis and highlight the development process, the key changes in recommendations, and discuss the evidence supporting the changes. The didactic presentations will be followed by a discussion period with the ATS, CDC, and IDSA guidelines co-chairs.

CME and CE units are not being offered for this recording and there is no participant evaluation.

The training materials, including PDF handouts of the PowerPoint slides, are located here.

This training was recorded by Southeastern National Tuberculosis Center. 

Faculty:

   Payam Nahid, MD, MPH
   Guidelines co-chair, ATS
   Professor of Medicine
   Division of Pulmonary and Critical Care Medicine
   University of California, San Francisco
   San Francisco, CA

   Dick Menzies, MD
   Professor of Medicine, and of Epidemiology & Biostatistics
   Montreal Chest Clinic
   McGill University
   Montreal, Quebec, Canada

Facilitator:

   Lisa Chen, MD
   Professor of Medicine
   Division of Pulmonary and Critical Care Medicine
   Medical Director/Principal Investigator
   Curry International Tuberculosis Center (CITC)
   University of California, San Francisco
   San Francisco, CA

Panelists:

  David Ashkin, MD, FCCP
  Clinical Professor
  University of Florida
  Medical Director
  Southeastern National Tuberculosis Center (SNTC)
  TB Controller
  Division of Disease Control and Health Protection
  Florida Department of Health
  Gainesville, FL

  Andrew Vernon, MD, MHS
  Guidelines co-chair, CDC
  Chief
  Clinical Research Branch
  Division of Tuberculosis Elimination
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
  Centers for Disease Control and Prevention
  Atlanta, GA

  Susan E. Dorman, MD
  Guidelines co-chair, IDSA
  Professor of Medicine and International Health
  Johns Hopkins University School of Medicine
  Baltimore, MD